Clinical Trial Update: Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluates adoptive transfer of ex vivo generated polyomavirus-specific T-cells to treat progressive multifocal leukoencephalopathy. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Ex vivo generated polyomavirus-specific T-cells (polyomavirus-specific T-cell therapy)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Progressive Multifocal Leukoencephalopathy | EARLY_Phase 1 | Status: COMPLETED